About Baum, Hedlund, Aristei & Goldman, P.C.
Wendy Dolin is represented by the national law firm of Baum, Hedlund, Aristei & Goldman, based in Los Angeles and the Chicago law firm, Rapoport Law Offices.
Baum Hedlund has the longest track-record handling SSRI (selective serotonin reuptake inhibitors) antidepressant litigation, having successfully handled thousands of individual antidepressant-related injury and death cases involving suicide, withdrawal syndrome and birth defects, since 1990. The firm has testified before the FDA on several occasions and met with several members of Congress about the adverse reactions and risks concerning SSRI antidepressants. Their work has been acknowledged as helping prompt the FDA to require black box suicidality warnings on all antidepressant labels, and they uncovered the SSRI cardio-birth defect connection, as well as pharmaceutical industry manipulation of the scientific literature through ghostwriting.
The Rapoport firm litigates personal injury, wrongful death and product liability cases and has a long track-record of success, winning numerous multi-million dollar jury awards. The firm is known for improving public safety by holding wrongdoers accountable when they act carelessly, resulting in harm to others.
Related News and Stories
Paxil Suicide Case Heads to Trial
Widow Blames Weak Warning Label on Generic Paxil for Husband’s Suicide
A Case of Mistaken Identity? Glaxo Faces a Lawsuit Over Generic Liability, Wall St. Journal
7th Circ. Denies GSK’s Appeal In Reed Smith Atty Suicide Case, Law 360
GSK and Catch 22, RxISK.org
Widow’s Lawsuit Alleges Weak Warning Label on Common Drug, NBC News Chicago
7th Cir. Denies GSK’s Writ of Mandamus in Generic Paxil Suicide Case, Harris Martin
GSK to Face Trial Over Death of Reed Smith Partner, National Law Journal
Paxil Faces Lawsuit over Generic Drug, Chicago Daily Law Bulletin
GSK Can’t Escape Suit Over Reed Smith Atty’s Suicide, Law 360
“Brand” New Law: Illinois Court Holds Brand Manufacturers Owe Duty of Care to Generic Users, Highbeam Business
FDA Testimony of Kim Witczak, Whose Husband Committed Suicide Shortly After Starting Zoloft
Families Testify and Ask FDA to Warn That Antidepressants Increase Suicide Risk